Suppr超能文献

Enterocutaneous fistula: medical and surgical management including patients with Crohn's disease.

作者信息

Orangio Guy R

机构信息

Georgia Colon and Rectal Surgical Associates, P.C., Atlanta, Georgia.

出版信息

Clin Colon Rectal Surg. 2010 Sep;23(3):169-75. doi: 10.1055/s-0030-1262984.

Abstract

Patients with inflammatory bowel disease (IBD) and especially Crohn's disease can be challenging for even the most seasoned of surgeons. Development of an enterocutaneous fistula (ECF) in these patients further adds a level of complexity that requires a well-planned and defined management strategy. The role of the surgeon in caring for these patients should be as the leader of a multidisciplinary team, directing the care of the other specialists, all while determining if, and when, the patient requires operative intervention. Although medical management has come a long way in these and similar patients, surgery is still needed in a vast majority of patients. Therefore, understanding the evaluation, initial management, and important technical considerations for care of IBD and other complex patients with ECFs is a difficult, yet much needed, task for which the surgeon should be prepared.

摘要

相似文献

1
Enterocutaneous fistula: medical and surgical management including patients with Crohn's disease.
Clin Colon Rectal Surg. 2010 Sep;23(3):169-75. doi: 10.1055/s-0030-1262984.
2
Enterocutaneous fistulas: a primer for radiologists with emphasis on CT and MRI.
Insights Imaging. 2017 Dec;8(6):537-548. doi: 10.1007/s13244-017-0572-3. Epub 2017 Sep 29.
3
Enterocutaneous fistula in severely active Crohn's disease: preoperative anti-TNF alpha treatment to limit bowel resection-report of a case.
Int J Colorectal Dis. 2019 Feb;34(2):369-373. doi: 10.1007/s00384-018-3206-4. Epub 2018 Nov 29.
6
Enterocutaneous fistula: a single-centre experience.
ANZ J Surg. 2010 Mar;80(3):178-81. doi: 10.1111/j.1445-2197.2009.05086.x.
7
Anoperineal lesions in Crohn's disease: French recommendations for clinical practice.
Tech Coloproctol. 2017 Sep;21(9):683-691. doi: 10.1007/s10151-017-1684-y. Epub 2017 Sep 19.
8
[Investigation of treatment and analysis of prognostic risk on enterocutaneous fistula in China: a multicenter prospective study].
Zhonghua Wei Chang Wai Ke Za Zhi. 2019 Nov 25;22(11):1041-1050. doi: 10.3760/cma.j.issn.1671-0274.2019.11.007.
9
Enterocutaneous fistula: analysis of clinical outcomes from a single Victorian tertiary referral centre.
ANZ J Surg. 2018 Jan;88(1-2):E30-E33. doi: 10.1111/ans.13686. Epub 2016 Jul 24.

引用本文的文献

1
The improvement of a refractory enterocutaneous fistula with colchicine in a patient with Crohn's disease who had an MEFV gene mutation.
Clin J Gastroenterol. 2025 Feb;18(1):81-88. doi: 10.1007/s12328-024-02061-3. Epub 2024 Nov 20.
2
Injectable Nanoengineered Adhesive Hydrogel for Treating Enterocutaneous Fistulas.
Acta Biomater. 2024 Jan;173:231-246. doi: 10.1016/j.actbio.2023.10.026. Epub 2023 Oct 28.
3
Management of Enterocutaneous Fistula in Crohn's Disease by Embolization With Glue Injection and Coiling: A Case Report.
Cureus. 2023 Aug 7;15(8):e43089. doi: 10.7759/cureus.43089. eCollection 2023 Aug.
4
Enterocutaneous Fistula: Open Repair after Unsuccessful Stenting-A Case Report.
Medicina (Kaunas). 2022 Feb 2;58(2):223. doi: 10.3390/medicina58020223.
5
Stable Gastric Pentadecapeptide BPC 157 and Wound Healing.
Front Pharmacol. 2021 Jun 29;12:627533. doi: 10.3389/fphar.2021.627533. eCollection 2021.
8
Enterocutaneous fistulas: a primer for radiologists with emphasis on CT and MRI.
Insights Imaging. 2017 Dec;8(6):537-548. doi: 10.1007/s13244-017-0572-3. Epub 2017 Sep 29.

本文引用的文献

1
The management of enterocutaneous fistula in a regional unit in the United kingdom: a prospective study.
Dis Colon Rectum. 2010 Feb;53(2):192-9. doi: 10.1007/DCR.0b013e3181b4c34a.
4
Use of infliximab within 3 months of ileocolonic resection is associated with adverse postoperative outcomes in Crohn's patients.
J Gastrointest Surg. 2008 Oct;12(10):1738-44. doi: 10.1007/s11605-008-0646-0. Epub 2008 Aug 15.
5
An analysis of predictive factors for healing and mortality in patients with enterocutaneous fistulas.
Aliment Pharmacol Ther. 2008 Nov 1;28(9):1111-21. doi: 10.1111/j.1365-2036.2008.03819.x. Epub 2008 Jul 30.
6
Tumor necrosis factor-alpha antibody for maintenance of remission in Crohn's disease.
Cochrane Database Syst Rev. 2008 Jan 23(1):CD006893. doi: 10.1002/14651858.CD006893.
7
Treatment strategies in 135 consecutive patients with enterocutaneous fistulas.
World J Surg. 2008 Mar;32(3):445-53. doi: 10.1007/s00268-007-9371-1.
8
Systematic management of postoperative enterocutaneous fistulas: factors related to outcomes.
World J Surg. 2008 Mar;32(3):436-43; discussion 444. doi: 10.1007/s00268-007-9304-z.
9
Effect of infliximab on short-term complications in patients undergoing operation for chronic ulcerative colitis.
J Am Coll Surg. 2007 May;204(5):956-62; discussion 962-3. doi: 10.1016/j.jamcollsurg.2006.12.044.
10
Infliximab in fistulizing Crohn's disease.
Gastroenterol Clin North Am. 2006 Dec;35(4):795-820. doi: 10.1016/j.gtc.2006.09.007.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验